Skip to main content
Sailong Pharmaceutical Group Co., Ltd. logo

Sailong Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 002898 ISIN · CNE1000032S5 LEI · 8368004F5Y6BSB6US681 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,116 across all filing types
Latest filing 2023-03-14 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002898

About Sailong Pharmaceutical Group Co., Ltd.

https://www.sailong.cn

Sailong Pharmaceutical Group Co., Ltd. is a pharmaceutical enterprise focused on the research, development, production, and marketing of high-end generic drugs and innovative formulations. The company maintains an integrated industrial chain encompassing active pharmaceutical ingredients (APIs) and finished dosage forms. Its product portfolio primarily targets therapeutic areas such as cardiovascular and cerebrovascular diseases, the digestive system, and anti-infective treatments. Key products include Monosialotetrahexosylganglioside Sodium Injection and Pantoprazole Sodium for Injection. The group emphasizes technological innovation and quality control to provide clinical solutions for complex medical conditions.

Recent filings

Filing Released Lang Actions
《董事会提名委员会工作细则》
Governance Information Classification · 95% confidence The document is titled as the 'Board of Directors Nomination Committee Working Rules' for a company, detailing the structure, responsibilities, and procedures of the nomination committee within the board. It focuses on governance practices related to board and senior management nominations, without any financial data, earnings, or regulatory filings. It is a governance-related internal rules document rather than a report or announcement. Therefore, it fits the category of Governance Information (CGR). The document length is 2188 characters, which is consistent with a detailed governance policy document rather than a brief announcement or report.
2023-03-14 Chinese
《董事会审计委员会工作细则》
Governance Information Classification · 95% confidence The document is titled as the 'Board Audit Committee Working Rules' of a company, detailing the structure, responsibilities, and procedures of the audit committee within the board of directors. It outlines governance and oversight functions related to auditing but does not contain any financial statements, audit reports, or results. It is a governance-related document describing internal rules and committee operations rather than an audit report or financial report. Therefore, it fits best under Governance Information (CGR). The document length is 2454 characters, which is relatively short but contains substantive governance content, not just an announcement or certification.
2023-03-14 Chinese
《董事会薪酬与考核委员会工作细则》
Governance Information Classification · 100% confidence The document is titled as the 'Board of Directors Remuneration and Assessment Committee Work Rules' of a company. It details the structure, responsibilities, and procedures of the remuneration and assessment committee under the board of directors. It focuses on governance aspects such as committee composition, duties, decision-making processes, and confidentiality. There is no financial data, earnings information, or report publication mentioned. The content is about internal governance rules related to board and senior management remuneration and assessment. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-03-14 Chinese
《董事会战略决策委员会工作细则》
Governance Information Classification · 95% confidence The document is titled as the working rules of the Board's Strategic Decision Committee of a company. It details the committee's composition, responsibilities, decision-making procedures, meeting rules, and confidentiality obligations. There is no financial data, no mention of financial results, no shareholder voting results, no legal proceedings, no capital changes, no earnings information, and no regulatory filings. The content focuses on governance structure and internal board committee rules, which aligns with governance information about the company's internal rules and board structure. The document length is short (1707 characters), and it is not an announcement of a report but the actual governance document. Therefore, the most appropriate classification is Governance Information (CGR).
2023-03-14 Chinese
关于聘任公司副总经理的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new company vice general manager, including details about the individual's background and qualifications. It does not contain financial data, audit information, or regulatory certifications. It is a management change announcement, specifically about senior management appointment. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused on management change, not a report or presentation.
2023-03-14 Chinese
《信息披露事务管理办法》
Governance Information Classification · 95% confidence The document is a detailed internal management policy titled 'Information Disclosure Management Measures' for a company, outlining the principles, responsibilities, procedures, and standards for information disclosure in compliance with Chinese securities laws and Shenzhen Stock Exchange rules. It does not contain financial statements, audit results, earnings data, or any specific report content. Instead, it sets out governance and procedural rules for disclosure, including roles of board members, management, and shareholders, as well as confidentiality and compliance measures. This type of document fits best under Governance Information (CGR), as it details the company's internal rules and governance practices related to information disclosure.
2023-03-14 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.